Shares of DURECT Co. (NASDAQ:DRRX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the five analysts that are covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 12-month price […]
StockNews.com began coverage on shares of Oncternal Therapeutics (NASDAQ:ONCT – Free Report) in a research note published on Sunday morning. The firm issued a hold rating on the stock. Separately, HC Wainwright reduced their price objective on Oncternal Therapeutics from $28.00 to $19.00 and set a buy rating on the stock in a research note […]
Richmond Brothers Inc. decreased its position in shares of MiMedx Group, Inc. (NASDAQ:MDXG – Free Report) by 5.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,404,352 shares of the company’s stock after selling 76,980 shares during the quarter. MiMedx Group accounts […]
DURECT (NASDAQ:DRRX) Stock Rating Reaffirmed by HC Wainwright wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright restated their buy rating on shares of Ocuphire Pharma (NASDAQ:OCUP – Free Report) in a research note released on Monday morning, Benzinga reports. The brokerage currently has a $20.00 target price on the stock. HC Wainwright also issued estimates for Ocuphire Pharma’s Q2 2024 earnings at ($0.29) EPS, Q3 2024 earnings at ($0.29) […]